{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:48:08Z","timestamp":1770274088332,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00432-022-04291-9","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:03:56Z","timestamp":1661803436000},"page":"4015-4023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases"],"prefix":"10.1007","volume":"149","author":[{"given":"Xiaoran","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongpo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuxin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"4291_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/mop.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez-Terrada D, Hiyama E, H\u00e4berle B, Malogolowkin M, Meyers R (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26:19\u201328. https:\/\/doi.org\/10.1097\/mop.0000000000000046","journal-title":"Curr Opin Pediatr"},{"key":"4291_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"4291_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/mot.0000000000000618","volume":"24","author":"E Hafberg","year":"2019","unstructured":"Hafberg E, Borinstein S, Alexopoulos S (2019) Contemporary management of hepatoblastoma. Curr Opin Organ Transplant 24:113\u2013117. https:\/\/doi.org\/10.1097\/mot.0000000000000618","journal-title":"Curr Opin Organ Transplant"},{"key":"4291_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hishiki","year":"2011","unstructured":"Hishiki T et al (2011) Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27:1\u20138. https:\/\/doi.org\/10.1007\/s00383-010-2708-0","journal-title":"Pediatr Surg Int"},{"key":"4291_CR5","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1200\/jco.19.01067","volume":"38","author":"E Hiyama","year":"2020","unstructured":"Hiyama E et al (2020) Outcome and late complications of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor 2 protocol. J Clin Oncol 38:2488\u20132498. https:\/\/doi.org\/10.1200\/jco.19.01067","journal-title":"J Clin Oncol"},{"key":"4291_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s1470-2045(18)30895-7","volume":"20","author":"H Katzenstein","year":"2019","unstructured":"Katzenstein H et al (2019) Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children\u2019s Oncology Group, multicentre, phase 3 trial. Lancet Oncol 20:719\u2013727. https:\/\/doi.org\/10.1016\/s1470-2045(18)30895-7","journal-title":"Lancet Oncol"},{"key":"4291_CR7","doi-asserted-by":"publisher","first-page":"e28655","DOI":"10.1002\/pbc.28655","volume":"67","author":"D Keino","year":"2020","unstructured":"Keino D et al (2020) Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse\/refractory hepatic cancer (FINEX pilot study). Pediatr Blood Cancer 67:e28655. https:\/\/doi.org\/10.1002\/pbc.28655","journal-title":"Pediatr Blood Cancer"},{"key":"4291_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2019.150856","volume":"28","author":"C Lake","year":"2019","unstructured":"Lake C, Tiao G, Bondoc A (2019) Surgical management of locally-advanced and metastatic hepatoblastoma. Semin Pediatr Surg 28:150856. https:\/\/doi.org\/10.1016\/j.sempedsurg.2019.150856","journal-title":"Semin Pediatr Surg"},{"key":"4291_CR9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/lt.24952","volume":"23","author":"C Lim","year":"2017","unstructured":"Lim C et al (2017) Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent-to-treat analysis. Liver Transplant 23:1553\u20131563. https:\/\/doi.org\/10.1002\/lt.24952","journal-title":"Liver Transplant"},{"key":"4291_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030407","author":"J Marin","year":"2019","unstructured":"Marin J, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias R (2019) Mechanisms of anticancer drug resistance in hepatoblastoma. Cancers. https:\/\/doi.org\/10.3390\/cancers11030407","journal-title":"Cancers"},{"key":"4291_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00383-002-0906-0","volume":"19","author":"T Matsunaga","year":"2003","unstructured":"Matsunaga T et al (2003) Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 19:142\u2013146. https:\/\/doi.org\/10.1007\/s00383-002-0906-0","journal-title":"Pediatr Surg Int"},{"key":"4291_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/s1470-2045(16)30598-8","volume":"18","author":"R Meyers","year":"2017","unstructured":"Meyers R et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic Tumors International Collaboration. Lancet Oncol 18:122\u2013131. https:\/\/doi.org\/10.1016\/s1470-2045(16)30598-8","journal-title":"Lancet Oncol"},{"key":"4291_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","volume":"49","author":"M Semeraro","year":"2013","unstructured":"Semeraro M et al (2013) Relapses in hepatoblastoma patients: clinical characteristics and outcome\u2013experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer (oxf Engl) 49:915\u2013922. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.003","journal-title":"Eur J Cancer (oxf Engl)"},{"key":"4291_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","volume":"34","author":"D Sharma","year":"2017","unstructured":"Sharma D, Subbarao G, Saxena R (2017) Hepatoblastoma. Semin Diagn Pathol 34:192\u2013200. https:\/\/doi.org\/10.1053\/j.semdp.2016.12.015","journal-title":"Semin Diagn Pathol"},{"key":"4291_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","volume":"48","author":"A Towbin","year":"2018","unstructured":"Towbin A et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 48:536\u2013554. https:\/\/doi.org\/10.1007\/s00247-018-4078-z","journal-title":"Pediatr Radiol"},{"key":"4291_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1200\/jco.21.00803","volume":"40","author":"A Trobaugh-Lotrario","year":"2022","unstructured":"Trobaugh-Lotrario A et al (2022) Small cell undifferentiated histology does not adversely affect outcome in hepatoblastoma: a report from the Children\u2019s Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol 40:459\u2013467. https:\/\/doi.org\/10.1200\/jco.21.00803","journal-title":"J Clin Oncol"},{"key":"4291_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11597740-000000000-00000","volume":"14","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani R, Furman W, Fuchs J, Warmann S, Malogolowkin M (2012) Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs 14:221\u2013232. https:\/\/doi.org\/10.2165\/11597740-000000000-00000","journal-title":"Paediatr Drugs"},{"key":"4291_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/bjs.9681","volume":"102","author":"R Venkatramani","year":"2015","unstructured":"Venkatramani R, Stein J, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L (2015) Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg 102:108\u2013113. https:\/\/doi.org\/10.1002\/bjs.9681","journal-title":"Br J Surg"},{"key":"4291_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/138920107780487456","volume":"8","author":"S Warmann","year":"2007","unstructured":"Warmann S, Fuchs J (2007) Drug resistance in hepatoblastoma. Curr Pharm Biotechnol 8:93\u201397. https:\/\/doi.org\/10.2174\/138920107780487456","journal-title":"Curr Pharm Biotechnol"},{"key":"4291_CR20","doi-asserted-by":"publisher","first-page":"e29389","DOI":"10.1002\/pbc.29389","volume":"69","author":"K Watanabe","year":"2022","unstructured":"Watanabe K et al (2022) Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: analysis of the JPLT3-H pilot study. Pediatr Blood Cancer 69:e29389. https:\/\/doi.org\/10.1002\/pbc.29389","journal-title":"Pediatr Blood Cancer"},{"key":"4291_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01230-2","author":"P Wu","year":"2022","unstructured":"Wu P, Rangaswami A (2022) Current approaches in hepatoblastoma-new biological insights to inform therapy. Curr Oncol Rep. https:\/\/doi.org\/10.1007\/s11912-022-01230-2","journal-title":"Curr Oncol Rep"},{"key":"4291_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaoncol.2019.4477","volume":"6","author":"Y Xia","year":"2020","unstructured":"Xia Y et al (2020) Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial. JAMA Oncol 6:255\u2013263. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4477","journal-title":"JAMA Oncol"},{"key":"4291_CR23","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.surg.2019.11.005","volume":"169","author":"H Xing","year":"2021","unstructured":"Xing H et al (2021) Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: a multicenter propensity score matching analysis. Surgery 169:911\u2013920. https:\/\/doi.org\/10.1016\/j.surg.2019.11.005","journal-title":"Surgery"},{"key":"4291_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.surg.2020.12.035","volume":"170","author":"I Ziogas","year":"2021","unstructured":"Ziogas I et al (2021) Management of hepatoblastoma in the United States: can we do better? Surgery 170:579\u2013586. https:\/\/doi.org\/10.1016\/j.surg.2020.12.035","journal-title":"Surgery"},{"key":"4291_CR25","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1200\/jco.2009.22.4857","volume":"28","author":"J Zs\u00edros","year":"2010","unstructured":"Zs\u00edros J et al (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28:2584\u20132590. https:\/\/doi.org\/10.1200\/jco.2009.22.4857","journal-title":"J Clin Oncol"},{"key":"4291_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/s1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J et al (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 14:834\u2013842. https:\/\/doi.org\/10.1016\/s1470-2045(13)70272-9","journal-title":"Lancet Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04291-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04291-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04291-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:15:41Z","timestamp":1688213741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04291-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04291-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study. Ethical approval was obtained from our Research Ethics Board to collect and analyze the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}